Drug Class
|
Drug Name
|
Change
|
Alzheimer’s
|
Entire class
|
Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|
Antiemetics
|
Entire class
|
Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|
Antiplatelets
|
Entire class
|
Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|
Attention Deficit/
Hyperactivity Disorder
|
Entire class
|
Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|
Atypical Antipsychotics
|
Entire class
|
Changed title of drug class to “Second Generation Antipsychotic Drugs”
|
Atypical Antipsychotics
(Second Generation Antipsychotics)
|
Entire class
|
Client must have tried and failed, or is intolerant to, 3 preferred products before receiving a non-preferred product for the same indication.
|
Long-Acting Insulins
|
Entire class
|
Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|
Multiple Sclerosis
|
Entire class
|
Clarifying try/fail statement:
Client must have tried and failed, or is intolerant to, all preferred active ingredients before receiving a non-preferred product for the same indication.
|
Nasal Corticosteroids
|
Entire class
|
Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|
Newer Sedative/ Hypnotics
|
Entire class
|
Added subclasses. Removed all EA and PA requirements, only PDL rules apply. Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|
Targeted Immune Modulators
|
Inflectra®
|
Added to class as non-preferred, unstudied, not subject to TIP/DAW.
|
Targeted Immune Modulators
|
Entire class
|
Removed all EA and PA requirements, only PDL rules apply. Client must have tried and failed, or is intolerant to, all preferred products before receiving a non-preferred product for the same indication.
|